Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 340(1): 309-17, 2006 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-16364256

RESUMO

The hallmarks of prion diseases are the conversion of the normal prion into an abnormal protease resistant isoform and its brain accumulation. Purification of the native abnormal prion isoform for biochemical and biophysical studies has been hampered by poor recovery from brain tissue. An epithelial cell transfected with the ovine VRQ allele prion, called Rov9, has been used to select prion high-producer cells by flow cytometry. The representative clone 4 described here produced 6.2 microg of cellular prion protein per mg of total protein extract, representing 8- to 10-fold the amount produced by the Rov9 parental cells. After exposure to the scrapie agent (PG128/98), clone 4 produced 2.6 microg of abnormal isoform per mg of total protein. When infected clone 4 cell cultures were treated with tunicamycin, 80% of the abnormal isoform was deglycosylated. The infectivity of the prions produced in clone 4 cultures was confirmed in a mouse bioassay. Such high-producer clones represent new tools for producing large amounts of glycosylated and/or non-glycosylated PrP(Sc) and for a powerful screening of clinical samples' infectivity.


Assuntos
Separação Celular/métodos , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Citometria de Fluxo/métodos , Rim/citologia , Rim/metabolismo , Proteínas PrPSc/biossíntese , Animais , Linhagem Celular , Clonagem Molecular/métodos , Proteínas PrPSc/genética , Proteínas PrPSc/isolamento & purificação , Engenharia de Proteínas/métodos , Coelhos , Transfecção/métodos
2.
Anticancer Res ; 25(3B): 2129-33, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16158954

RESUMO

Fucoidans inhibit tumour cell adhesion to various substrata, but their mechanisms of action are not fully understood. Using 3H-fucoidan, we observed that fucoidan binds to fibronectin, this binding being saturable and sensitive to ionic strength and pH. The interaction occurred on at least four different sites along the polypeptide chain, two of them being the heparin-binding sequences. Moreover, when MDA-MB-231 tumour cells were exposed to DTAF-fucoidan, internalization occurred and punctuated vesicles were observed in the perinuclear region. The treated cells also showed a different morphology with a cytoskeleton devoid of vinculin and a reorganiztion of the repartition of the integrin-alpha5 subunit on the cell surface. Based on these data, we hypothesize that fucoidan inhibits the adhesion of MDA-MB-231 cells to fibronectin i) by blocking the protein's heparin- and cell-binding domains, ii) by modulating the reorganization of the integrin alpha5 subunit and iii) by down-regulating the expression of vinculin.


Assuntos
Adenocarcinoma/patologia , Antineoplásicos/farmacologia , Neoplasias da Mama/patologia , Fibronectinas/metabolismo , Polissacarídeos/farmacologia , Actinas/metabolismo , Adenocarcinoma/metabolismo , Antineoplásicos/metabolismo , Neoplasias da Mama/metabolismo , Adesão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Membrana Celular/metabolismo , Membrana Celular/patologia , Relação Dose-Resposta a Droga , Matriz Extracelular/metabolismo , Matriz Extracelular/patologia , Humanos , Integrina alfa5/biossíntese , Integrina beta1/biossíntese , Polissacarídeos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...